2020
DOI: 10.1111/dth.13880
View full text
|
Sign up to set email alerts
|
Share

Abstract: crucial. In this era of biologic therapies, misdiagnosis, and the use of inappropriate drugs in CTCL may lead to catastrophic outcomes. If dupilumab had a role in progression or histopathological presentation is unknown. More studies are needed, and a more accurate and careful indication of biologic therapies is imperative. CONFLICT OF INTEREST The authors declare no conflicts of interest. AUTHOR CONTRIBUTIONS Denis Miyashiro designed the research, gathered and analyzed the data, and wrote the majority of the …

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
1
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals